Salbutamol
- Generic Name
- Salbutamol
- Brand Names
- Airomir, Airsupra, Combivent, Proair, Proventil, Ventolin
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21NO3
- CAS Number
- 18559-94-9
- Unique Ingredient Identifier
- QF8SVZ843E
- Background
Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and...
- Indication
Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known t...
- Associated Conditions
- Asthma, Asthmatic Bronchitis, Bronchial Asthma, Bronchoconstriction, Bronchospasm, Chronic Asthma, Chronic Bronchitis, Cough, Emphysema, Exacerbation of asthma, Exercise-Induced Bronchospasm, Hyperkalemia, Wheezing, Excess mucus or phlegm
- Associated Therapies
- Airway secretion clearance therapy, Bronchodilation
CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma
- Conditions
- Interventions
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Università degli Studi di Ferrara
- Target Recruit Count
- 80
- Registration Number
- NCT06482294
- Locations
- 🇮🇹
Research Centre on Asthma and COPD, University of Ferrara, Ferrara, Italy
Deciphering a Novel and Unique Brown Adipose Tissue Depot in Women
- Conditions
- Interventions
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Universidad de Almeria
- Target Recruit Count
- 40
- Registration Number
- NCT06426082
- Locations
- 🇪🇸
Universidad de Almería, Almería, Spain
The Regulatory Function of Inhaled Asthma Medication Salbutamol on Thermogenesis
- Conditions
- Interventions
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Tongji University
- Target Recruit Count
- 30
- Registration Number
- NCT06319183
Nebulized Salbutamol in Acute Renal Colic
- Conditions
- Interventions
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Oman Medical Speciality Board
- Target Recruit Count
- 214
- Registration Number
- NCT06276231
Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing Tonsillectomy
- Conditions
- Interventions
- First Posted Date
- 2023-12-06
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 87
- Registration Number
- NCT06158893
Video Assisted Study of Salbutamol Response in Viral Wheezing
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- University of Oulu
- Target Recruit Count
- 50
- Registration Number
- NCT06093152
- Locations
- 🇫🇮
Department of Pediatrics, Oulu University Hospital, Oulu, Finland
5 Versus 10 Units of Insulin in Hyperkalemia Management
- Conditions
- Interventions
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Oman Medical Speciality Board
- Target Recruit Count
- 336
- Registration Number
- NCT06036823
- Locations
- 🇴🇲
Sultan Qaboos University hospital, Seeb, Muscat, Oman
Evaluating Bronchodilator Response in Patients With Bronchiectasis
- Conditions
- Interventions
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 96
- Registration Number
- NCT05932316
- Locations
- 🇮🇱
Rambam Health Campus, Haifa, Israel
Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients
- Conditions
- Interventions
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 36
- Registration Number
- NCT05860244
- Locations
- 🇫🇷
Hôpital Pitié Salpêtrière, Paris, France
Treating Exacerbations of Asthma With Oral Montelukast in Children
- Conditions
- Interventions
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT05819541
- Locations
- 🇺🇸
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.